Validation of Heart Failure Events in the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Participants Assigned to Doxazosin and Chlorthalidone

BACKGROUND: The Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) is a randomized, double-blind, active-controlled trial designed to compare the rate of coronary heart disease events in high-risk hypertensive participants initially randomized to a diuretic (chlorth...

Descripción completa

Detalles Bibliográficos
Autores principales: Piller, Linda B, Davis, Barry R, Cutler, Jeffrey A, Cushman, William C, Wright, Jackson T, Williamson, Jeff D, Leenen, Frans HH, Einhorn, Paula T, Randall, Otelio S, Golden, John S, Haywood, L Julian
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2002
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC149403/
https://www.ncbi.nlm.nih.gov/pubmed/12459039
http://dx.doi.org/10.1186/1468-6708-3-10

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC149403/
https://www.ncbi.nlm.nih.gov/pubmed/12459039
http://dx.doi.org/10.1186/1468-6708-3-10

Ejemplares similares